|
業務類別
|
Biotechnology |
|
業務概覽
|
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue. |
| 公司地址
| 2101 Cottontail Lane, Somerset, NJ, USA, 08873 |
| 電話號碼
| +1 737 317-5050 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.legendbiotech.com |
| 員工數量
| 2900 |
| Dr. Ying Huang, PhD |
Director and Chief Executive Officer |
-- |
10/03/2026 |
| Mr. Carlos Santos Garcia |
Chief Financial Officer |
-- |
10/03/2026 |
|
|
| Mr. Gareth Kung |
Independent Director |
10/03/2026 |
| Mr. Tomas J. Heyman |
Independent Director |
10/03/2026 |
| Dr. Fangliang Zhang, PhD |
Chairman of the Board |
10/03/2026 |
| Dr. Corazon Dating Sanders, PhD |
Independent Director |
10/03/2026 |
| Dr. Ying Huang, PhD |
Director and Chief Executive Officer |
10/03/2026 |
| Ms. Ye Wang, M.S. |
Director |
10/03/2026 |
| Dr. Darren Xiaohui Ji, M.D.,PhD |
Independent Director |
10/03/2026 |
| Dr. Peter Salovey, PhD |
Independent Director |
10/03/2026 |
| Dr. Patrick Casey, PhD |
Independent Director |
10/03/2026 |
| Mr. Jiange Robin Meng |
Director |
10/03/2026 |
| Dr. Li Mao, M.D. |
Independent Director |
10/03/2026 |
|
|
|
|
